Comments
Pharma major Ranbaxy Laboratories has fully redeemed $440 million (about Rs 1,985 crore) zero coupon convertible bonds.
In a filing to the Bombay Stock Exchange, the company said it has redeemed the convertible bonds, the maturity date for which is on March 18, 2011.
In 2006, the company had launched an offering of $400-million zero coupon foreign currency convertible bonds, with an option to allot additional bonds of up to $40 million.
Zero coupon convertible bonds are debt instruments that pay no interest and can be converted into common stock of the issue at a certain price.
The capital raising exercise was one of the largest by an Indian healthcare company at that time.
The bonds had a tenor of five years and one day and were convertible into equity shares at a premium of 60 per cent to the BSE closing price of Rs 447.70 as on February 15, 2006.
The yield to maturity of the bonds was set at 4.8 per cent per annum, the company had then said.
Meanwhile, the shares of Ranbaxy today closed at Rs 468.55 on the BSE, up 0.26 per cent from the previous close.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.